Corbus Pharmaceuticals Holdings, Inc. (CRBP): Cash & Equivalents
$28.49M
As of 2025-12-31
$23.37M
As of 2026-06-30
+18.8%
3-year compound annual growth
-19.7%
5-year compound annual growth
+8.7%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $28.49M | +65.7% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $17.20M | +25.3% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $13.72M | -19.3% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $17.00M | -32.0% | 2024-03-12, Balance as of period end |
| 2021-12-31 | $25.01M | -70.7% | 2023-03-07, Balance as of period end |
| 2020-12-31 | $85.43M | +169.1% | 2022-03-08, Balance as of period end |
| 2019-12-31 | $31.75M | -24.0% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $41.75M | -33.2% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $62.54M | +317.1% | 2019-03-12, Balance as of period end |
| 2016-12-31 | $14.99M | +21.5% | 2018-03-12, Balance as of period end |
| 2015-12-31 | $12.34M | +97.0% | 2017-03-08, Balance as of period end |
| 2014-12-31 | $6.26M | n/m | 2016-03-28, Balance as of period end |
| 2013-12-31 | $303.0K | n/a | 2015-02-10, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | 2025-12-31 | $28.49M | +65.7% |
| Climb Bio, Inc. (CLYM) | 2025-12-31 | $35.69M | -59.1% |
| Eledon Pharmaceuticals, Inc. (ELDN) | 2025-12-31 | $22.81M | +11.0% |
| Gyre Therapeutics, Inc. (GYRE) | 2025-12-31 | $37.07M | +213.8% |
| Gossamer Bio, Inc. (GOSS) | 2025-12-31 | $37.73M | -18.1% |
| Apimeds Pharmaceuticals US, Inc. (APUS) | 2025-12-31 | $1.64M | n/m |
| Cypherpunk Technologies Inc. (CYPH) | 2025-12-31 | $14.04M | -70.3% |
| PepGen Inc. (PEPG) | 2025-12-31 | $60.51M | +22.4% |
| Transcode Therapeutics, Inc. (RNAZ) | 2025-12-31 | $17.81M | +206.5% |
Compare CRBP, CLYM, ELDN, GYRE side by side · Screen every company in Pharmaceutical Preparations ↗